IBS is a chronic functional gut disorder affecting 10-15% of people worldwide making it one of the most Googled digestive conditions. Symptoms include recurring abdominal pain, bloating, and unpredictable bowel habits - diarrhea (IBS-D), constipation (IBS-C), or both (IBS-M). IBS is now understood to involve gut microbiome dysbiosis, low-grade intestinal inflammation, increased gut permeability, and gut-brain axis dysfunction. Targeted probiotics with clinical evidence for IBS are among the most evidence-backed interventions for improving quality of life.
